Familial lipoprotein lipase deficiency

Advocacy intelligence hub — real-time data for patient organizations

View full disease page →Search clinical trials →
Download CSV

At a Glance

Live from database

Regulatory Watchboard

5 events
Jan 2026CS-121 APOC3 Base Editing in Children and Adolescents With Hyperchylomicronemia

Shanghai Jiao Tong University School of Medicine — EARLY_PHASE1

TrialRECRUITING
Oct 2025CS-121 APOC3 Base Editing in FCS

CorrectSequence Therapeutics Co., Ltd — EARLY_PHASE1

TrialRECRUITING
Feb 2022A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRX) Administered to Adults With Familial Chylomicronemia Syndrome (FCS) Previously Treated With Volanesorsen

Ionis Pharmaceuticals, Inc. — PHASE3

TrialACTIVE NOT RECRUITING
Nov 2021A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) in Participants With Familial Chylomicronemia Syndrome (FCS)

Ionis Pharmaceuticals, Inc. — PHASE3

TrialACTIVE NOT RECRUITING
Dec 2019Postprandial Fatty Acid Metabolism in Subjects With Lipoprotein Lipase Deficiency

Université de Sherbrooke — NA

TrialRECRUITING

Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Financial Assistance

1 program

FINANCIAL LANDSCAPE SUMMARY

1

Total programs

1

Open now

1

Copay cards

Copay Assistance1

REDEMPLO

Unknown

OpenContact for detailsApply ↗

View all support programs on disease page →

Clinical Trial Landscape

5 active trials
2Phase 3
1N/A
2EARLY_PHASE1
5Total recruiting
Search clinical trials for Familial lipoprotein lipase deficiency

Recent News & Research

No recent news articles indexed yet for Familial lipoprotein lipase deficiency.
Search PubMed for Familial lipoprotein lipase deficiency

Browse all Familial lipoprotein lipase deficiency news →

Specialist Network

Top 5 by expertise

View all Familial lipoprotein lipase deficiency specialists →

Quick Actions